Mosapramine (Cremin) is an atypical antipsychotic used in Japan for the treatment of schizophrenia.[1][2] It is a potent dopamine antagonist with high affinity to the D2, D3, and D4 receptors,[3] and with moderate affinity for the 5-HT2 receptors.[4]
Clinical data | |
---|---|
Trade names | Cremin (クレミン, JP) |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral (tablets, oral solution) |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C28H35ClN4O |
Molar mass | 479.07 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |